VAXXINITY
Vaxxinity, Inc. is a U.S.-based, clinical stage biotechnology company, that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. Vaxxinity has a proprietary technology platform that has enabled the innovation of synthetic peptide vaccines designed to treat and prevent chronic diseases, including Alzheimer's, Parkinson's, migraine, and hypercholesterolemia, as well as infectious diseases, including COVID-19. Vaxxinity has designed its pipeline to achieve a historic global impact on human health.
VAXXINITY
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.vaxxinity.com
Total Employee:
11+
Status:
Active
Total Funding:
9.25 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Global Site Tag Mobile Non Scaleable Content IPv6
Similar Organizations
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Board_member
2022-01-01
Board_member
Current Employees Featured
Ulo Palm Chief Medical Officer @ Vaxxinity
Chief Medical Officer
2021-08-01
Sean Trigony Investor @ Vaxxinity
Investor
2020-07-01
Peter Diamandis Co-Founder and Director @ Vaxxinity
Co-Founder and Director
Peter Powchik Executive Vice President and Global Scientific Director @ Vaxxinity
Executive Vice President and Global Scientific Director
2023-07-01
Jason Pesile Senior Vice President, Finance & Accounting @ Vaxxinity
Senior Vice President, Finance & Accounting
2022-01-01
Christina Yi Chief Operating Officer @ Vaxxinity
Chief Operating Officer
2020-11-01
Greg Blatt Lead Director @ Vaxxinity
Lead Director
2021-07-01
Lou Reese Executive Chairman @ Vaxxinity
Executive Chairman
2020-03-01
Cyrille Gineste Director-Peptide Chemistry @ Vaxxinity
Director-Peptide Chemistry
2022-10-01
Lixia Wang Senior Vice President, Data Science @ Vaxxinity
Senior Vice President, Data Science
2021-10-01
Founder
Stock Details
Investors List
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Grant - Vaxxinity
White Buffalo Capital
White Buffalo Capital investment in Seed Round - Vaxxinity
Key Employee Changes
Official Site Inspections
http://www.vaxxinity.com Semrush global rank: 6.09 M Semrush visits lastest month: 1.13 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Vaxxinity.com lookup results from whois.squarespace.domains server:
- Domain created: 27th-Sep-2019
- Domain updated: 12th-Sep-2024
- Domain expires: 27th-Sep-2025 0 Years, 183 Days left
- Website age: 5 Years, 182 Days
- Registrar Domain ID: 2437769309_DOMAIN_COM-VRSN
- Registrar Url: http://domains2.squarespace.com
- Registrar WHOIS Server: whois.squarespace.domains
- Registrar Abuse Contact Email: abuse-complaints@squarespace.com
- Registrar Abuse Contact Phone: +1.6466935324
- Name server:
- NS-CLOUD-A1.GOOGLEDOMAINS.COM
- NS-CLOUD-A2.GOOGLEDOMAINS.COM
- NS-CLOUD-A3.GOOGLEDOMAINS.COM
- NS-CLOUD-A4.GOOGLEDOMAINS.COM
More informations about "Vaxxinity"
Vaxxinity - LinkedIn
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin …See details»
Vaxxinity
Vaxxinity, Inc. is no longer subject to reporting requirements under the Exchange Act or those required by the listing standards of a national securities exchange, the provisions of the Sarbanes-Oxley Act of 2002, as amended …See details»
Vaxxinity, Inc. Company Profile | Merritt Island, FL | Competitors ...
Find company research, competitor information, contact details & financial data for Vaxxinity, Inc. of Merritt Island, FL. Get the latest business insights from Dun & Bradstreet.See details»
Vaxxinity Company Profile 2025: Stock Performance & Earnings
Vaxxinity General Information Description. Vaxxinity Inc is a biotechnology company committed to democratizing healthcare across the globe. The company is pioneering a new class of …See details»
Vaxxinity Inc Cl A (VAXX) Profile - The Globe and Mail
Dec 24, 2013 See the company profile for Vaxxinity Inc Cl A (VAXX) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Vaxxinity Inc. Company & People | VAXX | Barron's
Vaxxinity, Inc. is a biotechnology company that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. The company uses its synthetic peptide vaccine …See details»
VAXX | Vaxxinity Inc. Company Profile & Executives - WSJ
Company profile for Vaxxinity Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed VAXX description & address.See details»
Vaxxinity CEO Mei-Mei Hu: Advancing Vaccine …
May 19, 2021 UB-612: Vaxxinity’s Covid-19 vaccine candidate. Hu describes Vaxxinity’s Covid-19 vaccine candidate as “the not-so-scary vaccine you would give to your kids” thanks to its very low reactogenicity profile. “It’s super safe …See details»
Vaxxinity, Inc.’s Initial Public Offering - Cravath
Nov 29, 2021 Cravath represented Vaxxinity, Inc. in connection with its initial public offering. Vaxxinity is a U.S.‑based global biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize …See details»
Vaxxinity, Inc. (VAXX) Company Information - Simply Wall St
Vaxxinity, Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day. …See details»
Vaxxinity hopes its Covid jab technology will help treat Alzheimer’s
Jun 13, 2021 Vaxxinity is the US-based affiliate of United Biomedical, a Taiwanese pharmaceuticals group founded by Wang Chang-yi, Hu’s mother. It is also developing drugs …See details»
CEPI to co-fund Vaxxinity's pivotal Phase 3 UB-612 heterologous …
April 6, 2022; OSLO, Norway and DALLAS, USA: The Coalition for Epidemic Preparedness Innovations (CEPI) and Vaxxinity, Inc. (Nasdaq: VAXX), a US company pioneering the …See details»
Vaxxinity Announces Collaboration on Space Medicine Research …
CAPE CANAVERAL, Fla., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today …See details»
VAXX Stock Price Quote | Morningstar
5 days ago Vaxxinity Inc is a biotechnology company committed to democratizing healthcare across the globe. The company is pioneering a new class of synthetic, peptide-based active …See details»
Vaxxinity, Inc. (VAXX) - Yahoo Finance
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United …See details»
Vaxxinity, Inc. (VAXX) Latest Stock News & Headlines - Yahoo …
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates. CAPE CANAVERAL, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. …See details»
Vaxxinity (OTCPK:VAXX) - Stock Price, News & Analysis - Simply …
4 days ago Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the …See details»
Vaxxinity: supplanting mAbs with vaccines for chronic disease
Nov 7, 2020 Vaxxinity aims to disrupt the biologics market with a vaccine platform that replaces mAbs for chronic disease by inducing patients’ immune systems to manufacture therapeutic …See details»
Vaxxinity, Inc. (VAXX) Stock Price, News, Quote & History - Yahoo …
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United …See details»
VAXX Stock Alert: 10 Things to Know About Newly Public Vaxxinity ...
Nov 15, 2021 Vaxxinity reported revenue of $440,000 in the six months ending June 30, 2020. Its net loss in the same period was $10 million. Vaxxinity stated that it expects proceeds of …See details»